14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Saturday,<br />
May 1, 2004<br />
Sunday,<br />
May 2, 2004<br />
Scientific Programme Overview<br />
13<br />
14<br />
15<br />
16<br />
17<br />
18<br />
19<br />
20<br />
21<br />
07<br />
08<br />
09<br />
10<br />
11<br />
12<br />
13<br />
14<br />
15<br />
16<br />
17<br />
18<br />
Auditorium<br />
Ground Floor<br />
Small Hall Panorama Hall<br />
18.00 – 19.30<br />
Opening<br />
Ceremony<br />
p. 176<br />
19.30 – 21.00<br />
Welcome<br />
Reception<br />
p. 176<br />
10.00 – 12.00<br />
Emerging<br />
respiratory virus<br />
infections<br />
14.00 – 15.00<br />
SARS: health<br />
care workers<br />
at risk<br />
14.00 – 17.30<br />
Staphylococcal<br />
small colony<br />
variants<br />
Educational<br />
Workshop<br />
arranged with<br />
ASM<br />
page 18 Final Programme<br />
p. 27<br />
07.15 – 08.15<br />
Should we treat<br />
asymptomatic<br />
bacteriuria<br />
p. 31<br />
08.30 – 09.30 �Campylobacter, from obscurity to<br />
celebrity(Excellence<br />
Award Lecture)<br />
p. 31<br />
– 18.45<br />
�17.45<br />
Catastrophes<br />
after crossing<br />
species barriers<br />
p. 41<br />
10.00 – 12.00<br />
Future<br />
targets for<br />
therapeutic<br />
interventions<br />
in sepsis<br />
14.00 – 15.00<br />
Helicobacter<br />
update 2004<br />
14.00 – 16.00<br />
ESCMID<br />
<strong>European</strong><br />
Council<br />
Meeting<br />
p. 25<br />
10.00 – 12.00<br />
Gram-positive<br />
pathogens vs.<br />
new therapies<br />
Chiron<br />
14.00 – 15.00<br />
Methicillinresistant<br />
1st Floor<br />
Meeting Hall I Club A<br />
15.30 – 17.30<br />
New<br />
considerations in<br />
the management<br />
<strong>of</strong> serious<br />
infections<br />
Wyeth<br />
10.00 – 12.00<br />
MRSA – an<br />
endemic<br />
challenge for<br />
hospital<br />
clinicians<br />
Pfizer<br />
14.30 – 17.30<br />
An introduction<br />
to pharmako -<br />
kinetics <strong>and</strong> pharmaco<br />
-<br />
dy namics<br />
10th ISAP<br />
Educational<br />
Workshop<br />
p. 29 p. 29<br />
07.15 – 08.15<br />
Interpretative reading<br />
<strong>of</strong> antibiotic<br />
susceptibility tests<br />
p. 31<br />
10.00 – 12.00<br />
Interventions<br />
to improve<br />
antibiotic<br />
prescription<br />
14.00 – 15.00<br />
Prevention <strong>of</strong> Clos-<br />
tridium difficile<br />
p. 37 p. 37 S. aureus p. 37 disease p. 37<br />
15.30 – 17.30<br />
15.30 – 17.30<br />
Strategies in anti- Redefining<br />
fungal therapy: broad-spectrum<br />
from prophylaxis antibiotics in<br />
to curative the new<br />
treatment millenium<br />
Gilead<br />
15.30 – 17.30<br />
Pan-european<br />
infectious<br />
disease<br />
surveillance<br />
15.30 – 17.30<br />
The threat posed<br />
by Rickettsiales<br />
<strong>and</strong> other<br />
arthropod-borne<br />
pathogens<br />
2nd Floor<br />
Forum Hall<br />
10.00 – 12.00<br />
New era in the<br />
management <strong>of</strong><br />
invasive fungal<br />
infections<br />
Merck<br />
p. 32 p. 32 p. 35 p. 35 p. 33 p. 35<br />
14.00 – 15.00<br />
Antimicrobial<br />
resistance: from<br />
bench to bedside<br />
15.30 – 17.30<br />
Resistance<br />
surveillance:<br />
local hotspots,<br />
global strategies<br />
Wyeth<br />
GlaxoSmithKline<br />
p. 41 p. 41 p. 38 p. 39 p. 41<br />
p. 37
Change language